drugset
drugset / Trial / NCT02333487

Positron Emission Tomography (PET) Study Investigating Dopamine and Serotonin Receptor Occupancy After Multiple Oral Dosing of Lu AF35700

NCT02333487 ↗

Phase 1 Completed 22 enrolled H. Lundbeck A/S
Non-randomizedParallel-groupOpen-labelTreatment

Summary

The purpose of this PET study is to verify the binding of Lu AF35700 after multiple oral dosing at the dopamine and the serotonin receptors in male patients with schizophrenia.

Timeline

Start
2014-12-30
Primary completion
2016-02-11
Completion
2016-02-11

Drugs

EvaluationDrugModalityDoseRoute
Subject Lu AF35700 Unknown 5 mg Oral

Indications

schizophrenia